Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Gains from Sales and Divestitures (2019 - 2025)

Historic Gains from Sales and Divestitures for Lipocine (LPCN) over the last 3 years, with Q3 2025 value amounting to $3625.0.

  • Lipocine's Gains from Sales and Divestitures changed N/A to $3625.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3625.0, marking a year-over-year change of. This contributed to the annual value of $628807.0 for FY2020, which is 15406.34% up from last year.
  • According to the latest figures from Q3 2025, Lipocine's Gains from Sales and Divestitures is $3625.0.
  • Lipocine's 5-year Gains from Sales and Divestitures high stood at $3625.0 for Q3 2025, and its period low was $2416.0 during Q1 2025.